Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Nivatrotamab (Hu3F8-BsAb), a humanized anti-GD2/CD3 bispecific antibody and T-cell engager specific to CD3 and GD2, is employed in the study of neuroblastoma [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry |
Description | Nivatrotamab (Hu3F8-BsAb), a humanized anti-GD2/CD3 bispecific antibody and T-cell engager specific to CD3 and GD2, is employed in the study of neuroblastoma [1]. |
Molecular Weight | N/A |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Nivatrotamab inhibitor inhibit